$220M Investment to Turn Delpharm’s Boucherville Site into Pharma Hub

Delpharm is proud to announce a major milestone in the modernization of its Boucherville facility, made possible by a $60 million government contribution unveiled today by Economy, Innovation and Energy Minister Christine Fréchette, alongside Health Minister Christian Dubé.

This contribution adds to the previously confirmed $60 million investment from the federal government, announced last March, along with $100 million in private capital, bringing the total to $220 million. By 2031, this investment will transform Delpharm’s Boucherville site into a worldclass pharmaceutical facility. 

“I’m proud to announce this $60-million investment in a company that contributes to the prosperity of Québec’s life sciences sector. By partnering with Delpharm and investing in its success, our government is ensuring our supply chains are strengthened and demand from the hospital market is sustained. This partnership will positively.

“Delpharm is a strategic supplier to Québec’s healthcare network, which makes heavy use of the products designed by the Boucherville-based company. Its manufacturing site is the largest sterile injectable drug production facility in Canada, supplying a significant portion to the Québec and Canadian markets. This investment will allow Delpharm to bolster its innovation and production capacity. Congratulations to Delpharm on this promising expansion!”

Christian Dubé, Minister of Health
“We would like to acknowledge the commitment of the Ministry of Economy, Innovation and Energy, a key partner in strengthening Québec’s pharmaceutical autonomy. We also wish to recognize our long-standing partner Sandoz, with whom we have renewed a 10-year contract to produce generic hospital medicines. This agreement guarantees patients in Québec and across Canada a local, stable, and reliable supply.”

Tangible benefits for Québec
Thanks to the support of the provincial government, this project will generate tangible benefits for Québec’s economy and society:
• More than 500 specialized jobs preserved;
• $100 million injected into the local economy each year through salaries and purchases from Québec suppliers.
Delpharm will repay over time $105 of the $120 million in government support, in addition to dividends to be paid by the company to the Québec government.